Skip to main content
X4 Pharmaceuticals, Inc logo

X4 Pharmaceuticals, Inc — Investor Relations & Filings

Ticker · XFOR ISIN · US0428731097 LEI · 549300R0UFVPXWP86U94 US Manufacturing
Open in API
Filings indexed 784 across all filing types
Latest filing 2021-04-09 Regulatory Filings
Country US United States of America
Listing US XFOR

About X4 Pharmaceuticals, Inc

https://www.x4pharma.com/

X4 Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare diseases of the immune system. The company focuses on diseases resulting from the dysfunction of the CXCR4 pathway, a key signaling pathway for immune cell trafficking. Its lead product, XOLREMDI™ (mavorixafor), is an oral, selective antagonist of the CXCR4 receptor. It is approved for use in patients aged 12 and older with WHIM syndrome (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) to increase the number of circulating neutrophils and lymphocytes. The company's pipeline includes further investigation of mavorixafor for other chronic neutropenic disorders.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated April 9, 2021. It announces that the company posted an updated corporate presentation on its website and provides a link to access it. The document explicitly states that the information is furnished under Item 7.01 Regulation FD Disclosure and is not filed for purposes of Section 18 liabilities. The content is brief (3082 characters) and primarily serves as an announcement of the availability of a presentation rather than containing the presentation itself or detailed financial data. According to the MENU VS MEAL RULE, such a document is best classified as a Regulatory Filing (RNS) because it is an announcement and does not contain the actual investor presentation or detailed financial information. Therefore, the appropriate classification is Regulatory Filings (RNS) with high confidence.
2021-04-09 English
SC 13G/A
Major Shareholding Notification
2021-04-08 English
FORM 4
Director's Dealing
2021-04-07 English
FORM 4
Director's Dealing
2021-03-25 English
FORM 4
Director's Dealing
2021-03-25 English
FORM 4
Director's Dealing
2021-03-25 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.